CriticalClass ITerminated

FDA Food recall · Reported June 19, 2013

XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles

Q: Which agency issued this recall?

This recall was issued by the FDA Food on June 19, 2013. Severity: Critical. Recall number: F-1523-2013.

Q: Where was the recalled product distributed?

Distribution: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii.

Q: What are the health risks of consuming a recalled food product?

Recalled food products may contain contaminants, undeclared allergens, or harmful bacteria such as Salmonella, Listeria, or E. coli. Consuming these products can cause foodborne illness ranging from mild gastrointestinal symptoms to serious conditions requiring hospitalization. If you have consumed a recalled food product and experience symptoms, contact your healthcare provider and report to the FDA via MedWatch.

Undeclared Soy and Milk on the label.

Recall #: F-1523-2013
Affected scope: 16,268 units
Initiated: May 1, 2013

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Food →

View my saved recalls

Atlantic Pro Nutrients, Inc. dba Xymogen recalled XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support H… - a critical-severity action.

XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support H… was recalled by Atlantic Pro Nutrients, Inc. dba Xymogen in June 19, 2013. Reason: Undeclared Soy and Milk on the label.. Check the official notice for the remedy. Verify recall #F-1523-2013 with the FDA Food before acting.

The recall

Atlantic Pro Nutrients, Inc. dba Xymogen issued this critical-severity FDA Food recall-Undeclared Soy and Milk on the label..

Critical
severity level: 16K units
affected scope: Class I
classification: June 19, 2013
reported

Sourced from official FDA Food enforcement records. Verify recall #F-1523-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles

Reason for recall

Undeclared Soy and Milk on the label.

Recall Profile

Structured summary of the FDA Food recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Critical (Class I)
Status	Terminated
Recall number	F-1523-2013
Date reported	June 19, 2013
Date initiated	May 1, 2013
Recalling firm	Atlantic Pro Nutrients, Inc. dba Xymogen
Firm location	Orlando, FL
Affected scope	16,268 units
Distribution	AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii

Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

16,268 units units affected - limited or regional distribution scale.

Regional (<10K units) -

Multi-state (10K – 100K units) ✓ This recall

Large-scale (100K – 1M units) -

Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (F-1523-2013) and product description against the item you own. Search the archive
Confirm the current status with FDA Food before acting, recall details can be updated.
This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles. Recalled by Atlantic Pro Nutrients, Inc. dba Xymogen. Units affected: 16,268 units.

Why was this product recalled? ▼

Undeclared Soy and Milk on the label.

Which agency issued this recall? ▼

This recall was issued by the FDA Food on June 19, 2013. Severity: Critical. Recall number: F-1523-2013.

Where was the recalled product distributed? ▼

Distribution: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii.

What are the health risks of consuming a recalled food product? ▼

Recalled food products may contain contaminants, undeclared allergens, or harmful bacteria such as Salmonella, Listeria, or E. coli. Consuming these products can cause foodborne illness ranging from mild gastrointestinal symptoms to serious conditions requiring hospitalization. If you have consumed a recalled food product and experience symptoms, contact your healthcare provider and report to the FDA via MedWatch.

Nationwide recalls with similar severity or category timing

Food and dietary-supplement notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Critical), closest by report date among other firms and states.

JEEP 2002-2007: FUEL SYSTEM, GASOLINE:STO… 2013-06-19 CHEVROLET,GMC,ISUZU 2001-2011: ELECTRICAL… 2013-06-19 Rugby NATURAL IRON SUPPLEMENT Ferrous Sul… 2013-06-19 Pure Herbs, Ltd. Natural Herbal Extracts … 2013-06-19

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Cefazolin, injection, 1 gram per vial, 25… 2013-06-19 Amoxicillin for Oral Suspension, USP 400m… 2013-06-19 Fentanyl Transdermal System, 50 mcg/h, 1 … 2013-06-19 Sodium Sulfacetamide 10% and Sulfur 5% Lo… 2013-06-26

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Food, reported June 19, 2013. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026